Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-11 @ 6:57 AM
Study NCT ID:
NCT02492568
Status:
COMPLETED
Last Update Posted:
2020-08-17
First Post:
2015-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
Sponsor:
The Netherlands Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
M14PRT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |